[Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment].

Jian Xu(University of California, Los Angeles), Angelo Paradiso(Universidad de Oviedo), Evaristo Maiello(Casa Sollievo della Sofferenza), Anita Mangia(Istituti di Ricovero e Cura a Carattere Scientifico), Francesco Giuliani(Ospedale San Paolo), Giuseppe Colucci, Bu dong Zhu, Gianni Simone(Istituti di Ricovero e Cura a Carattere Scientifico), Severino Montemurro(Istituti di Ricovero e Cura a Carattere Scientifico)
PubMed
May 1, 2005
Cited by 3

Related Papers

Signatures of mutational processes in human cancer
|Nature|2013|10.1k
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
|The Lancet Oncology|2020|333
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245